Orphan designation: Upifitamab rilsodotin Treatment of ovarian cancer, 09/12/2022 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 12 March 2025 - 16:09

Orphan designation: Upifitamab rilsodotin Treatment of ovarian cancer, 09/12/2022 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-22-2723

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters